Suchergebnisse - "Lüftner, Diana"

PubPharm (267)

1

ABC7 Consensus : Assessment by a German Group of Experts

enthalten in: Breast care (Basel, Switzerland) | 2024

von Ditsch, N. | Untch, M. | Fasching, P. | +12

2

Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer : Results from the open-label, multicentre, non-interventional BRAWO study

enthalten in: International journal of cancer | 2024

von Lüftner, D. | Schuetz, F. | Schneeweiss, A. | +14

3

Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole : Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Fasching, P. | Decker, T. | Hartkopf, A. | +18

4

Radiotherapy statements of the 18th St. Gallen International Breast Cancer Consensus Conference-a German expert perspective

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2024

von Krug, D. | Banys-Paluchowski, M. | Brucker, S. | +19

5

Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland : Interim Results of the Prospective, Observational ELEANOR Study

enthalten in: Breast care (Basel, Switzerland) | 2024

von Harbeck, N. | Wrobel, D. | Zaiss, M. | +19

6

Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy

enthalten in: Cancer treatment reviews | 2023

von Harbeck, N. | Kates, R. | Schinköthe, T. | +15

7

How detection of immune-related adverse events fails during transfer of patients between medical sectors

enthalten in: Journal of cancer research and clinical oncology | 2023

von Schmoranz, K. | Schötz, C. | Merkel, D. | +1

8

PRECYCLE: Multicenter, Randomized Phase IV Intergroup Trial to Evaluate the Impact of E Health-Based Patient Reported Outcome (PRO) Assessment on Quality of Life in Patients with Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Treated with Palbociclib and an Aromatase Inhibitor- or Palbociclib and Fulvestrant

enthalten in: ResearchSquare.com | 2023

von Degenhardt, T. | Fasching, P. | Lüftner, D. | +19

9

Update Breast Cancer 2023 Part 3 - Expert Opinions of Early Stage Breast Cancer Therapies

enthalten in: Geburtshilfe und Frauenheilkunde | 2023

von Kolberg, H. | Hartkopf, A. | Fehm, T. | +27

10

Treatment of Early Breast Cancer : The 18th St. Gallen International Breast Cancer Consensus Conference against the Background of Current German Treatment Recommendations

enthalten in: Geburtshilfe und Frauenheilkunde | 2023

von Untch, M. | Banys-Paluchowski, M. | Brucker, S. | +19

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[27]